학술논문
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study.
Document Type
Article
Author
Source
BMC Rheumatology; 2/4/2024, Vol. 8 Issue 1, p1-11, 11p
Subject
Language
ISSN
25201026